Langasog, Fe L.
HRN: 18-87-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2025
MUPIROCIN 2%, 15G (TUBE)
05/25/2025
06/01/2025
DERMAL
1
BID
NONHEALING WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes